REFERENCES
- Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51(6):1–16.
- National Heart, Lung, and Blood Institute, National Institutes of Health. Morbidity and mortality: 2008 chart book on cardiovascular, lung, and blood diseases. http://www.nhlbi.nih.gov//resources/docs/04a_chtbk.pdf. Accessed July 2009.
- Britton M. The burden of COPD in the UK: results from the Confronting COPD survey. Respir Med 2003; 97 (Suppl C):S71–S79.
- Hilleman DE, Dewan NA, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2001; 118:1278–1285.
- Hunter DJ, Fairfield G. Disease management. BMJ 1997; 315:50–53.
- Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupr'e A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention. Arch Intern Med 2003; 163(5):585–591.
- Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, del Pozo F, de Toledo P, Anto' JM, Rodri'quez-Roisin R, Decramer M; members of the CHRONIC Project. Integrated care prevents hospitalizations for exacerbations in COPD patients. Eur Respir J 2006; 28(1):123–130.
- Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 2004; 34(11):608–614.
- Farrero E, Escarrabill J, Prats E, Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy. Chest 2001; 119(2):364–369.
- Ofman JJ, Badamgarav E, Henning JM, Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 2004; 117:182–192.
- Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systemic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Int Med 2007; 167:551–561.
- Gallefoss F, Bakke PS. Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD-a 1 year follow-up randomized, controlled trial. Respir Med 2002; 96:424–431.
- Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C. Economic benefits of self-management education in COPD. Chest 2006; 130:1704–1711.
- Steuten LMG, Lemmens KMM, Nieboer AP, Vrijhoef HJM. Identifying potentially cost effective chronic care programs for people with COPD. Int J COPD 2009; 4:87–100.
- Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE. Disease management program for Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Am J. Respir Crit Care Med 2010; 182:890–896.
- Lipscomb J, Yabroff KR, Brown ML, Lawrence W, Barnett PG. Health care costing: data, methods, current applications. Med Care 2009; 47 (suppl 7):S1–S6.
- Taylor SJC, Candy B, Bryar RM, Ramsay J, Vrijhoef HJM, Esmond G, Wedzicha JA, Griffiths CJ. Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence. BMJ doi:10.1136/bmj.38512.664167.8F (published 10 August 2005).
- Effing TW, Monninkhof EM, Van Der Valk PDLPM, Zielhuis GGA, Walters EH, Van Der Palen JJ, Zwerink M. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2007 4. Art. No: CD002990. DOI:0.1002/14651858.CD002990.pub2.